Pain predicts longer time to remission during treatment of recurrent depression

Journal of Clinical Psychiatry

Volumn 66, Issue 5, 2005, Pages 591-597

  Karp, Jordan F ^a   Scott, John ^a   Houck, Patricia ^a   Reynolds III, Charles F ^a   Kupfer, David J ^a   Frank, Ellen ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DULOXETINE; FLUOXETINE; IMIPRAMINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; INTERPERSONAL PSYCHOTHERAPY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PAIN; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RACE DIFFERENCE; RASKIN SEVERITY OF DEPRESSION SCALE; RATING SCALE; RECURRENT DISEASE; REMISSION; SEX DIFFERENCE; SOMATIZATION; SUICIDAL BEHAVIOR; SYMPTOM CHECKLIST 90; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 19544377519     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0508     Document Type: Article

References (62)

1. Greden JF. Physical symptoms of depression: unmet needs. J Clin Psychiatry 2003;64(suppl 7):5-11
2. Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med 2003;163:2433-2445
3. Kocher R. The use of psychotropic drugs in the treatment of chronic, severe pains. Eur Neurol 1976;14:458-464
4. Gringras M. A clinical trial of Tofranil in rheumatic pain in general practice. J Int Med Res 1976;4(suppl 2):41-49
5. Kvinesdal B, Molin J, Froland A, et al. Imipramine treatment of painful diabetic neuropathy. JAMA 1984;251:1727-1730
6. Bromm B, Meier W, Scharein E. Imipramine reduces experimental pain. Pain 1986;25:245-257
7. Poulsen L, Arendt-Nielsen L, Brosen K, et al. The hypoalgesic effect of imipramine in different human experimental pain models. Pain 1995;60:287-293
8. Enggaard TP, Poulsen L, Arendt-Nielsen L, et al. The analgesic effect of codeine as compared to imipramine in different human experimental pain models. Pain 2001;92:277-282
9. Sindrup SH, Bach FW, Madsen C, et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003;60:1284-1289
10. Jung AC, Staiger T, Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med 1997;12:384-389
11. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1256
12. Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 1994;23:255-259
13. Sawynok J, Esser MJ, Reid AR. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 1999;82:149-158
14. Fishbain DA, Cutler R, Rosomoff HL, et al. Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med 2000;1:310-316
15. Merskey H, Bogduk N. Classification of Chronic Pain. Seattle, Wash: International Association for the Study of Pain Press; 1994:xi-xv
16. Byers MR, Bonica JJ. Peripheral pain mechanisms and nociceptor plasticity. In: Loeser JD, Butler SH, Chapman CR, et al, eds. Bonica's Management of Pain. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:26-72
17. Fava M, Wohlreich MM, Mallinckrodt CH, et al. Does the alleviation of painful physical symptoms associated with depression lead to higher remission rates? In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 17-22, 2003; San Francisco, Calif. NR 447:167
18. Lithner F. Venlafaxine in treatment of severe painful peripheral diabetic neuropathy [letter]. Diabetes Care 2000;23:1710-1711
19. Schreiber S, Bleich A, Pick CG. Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects: a possible opioid involvement in severe depression? J Mol Neurosci 2002;18:143-149
20. Songer DA, Schulte H. Venlafaxine for the treatment of chronic pain [letter]. Am J Psychiatry 1996;153:737
21. Taylor K, Rowbotham MC. Venlafaxine hydrochloride and chronic pain. West J Med 1996;165:147-148
22. Yilmaz ME, Kadiroglu AK, Kara IH, et al. Venlafaxine in the treatment of painful peripheral diabetic neuropathy in a uremic patient undergoing hemodialysis [letter]. MedGenMed 2002;4:23
23. Karp JF. Venlafaxine XR and chronic pelvic pain syndrome [letter]. J Clin Psychiatry 2004;65:880-881
24. Stahl SM, Entsuah R, Rudolph RL. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biol Psychiatry 2002;52:1166-1174
25. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234-241
26. Fava M. The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression. J Clin Psychiatry 2003;64(suppl 13):26-29
27. Frank, E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47:1093-1099
28. Frank E, Kupfer DJ. Maintenance treatment of recurrent unipolar depression: pharmacology and psychotherapy. In: Kemali D, Racagni G, eds. Chronic Treatments in Neuropsychiatry. New York, NY: Raven Press; 1985
29. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978;35:773-782
30. Raskin A, Schulterbrandt J, Reatig N, et al. Replication of factors of psychopathology in interview, ward behavior and self-report ratings of hospitalized depressives. J Nerv Ment Dis 1969;148:87-98
31. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978;35:837-844
32. Klerman GL, Weissman MM, Rounsaville BJ, et al. Interpersonal Psychotherapy of Depression. New York, NY: Academic Press, Basic Books Inc; 1984
33. Derogatis LR, Lazarus L. SCL-90-R, Brief Symptom Inventory, and matching clinical rating scales. In: Maruish M, ed. The Use of Psychological Testing for Treatment Planning and Outcome Assessment. Hillsdale, NJ: Erlbaum; 1994:217-248
34. Ghali WA, Quan H, Brant R, et al. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA 2001;286:1494-1497
35. Endicott J, Spitzer RL, Fleiss JL, et al. The Global Assessment Scale: a procedure for measuring overall severity of a psychiatric disturbance. Arch Gen Psychiatry 1976;33:766-771
36. Terre L, Poston WS, Foreyt J, et al. Do somatic complaints predict subsequent symptoms of depression? Psychother Psychosom 2003;72:261-267
37. Pancrazio JJ, Kamatchi GL, Roscoe AK, et al. Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther 1998;284:208-214
38. McCleane G. Pharmacological management of neuropathic pain. CNS Drugs 2003;17:1031-1043
39. Dworkin SF, Von Korff M, LeResche L. Multiple pains and psychiatric disturbance: an epidemiologic investigation. Arch Gen Psychiatry 1990;47:239-244
40. Lundeen TF, Sturdevant JR, George JM. Stress as a factor in muscle and temporomandibular joint pain. J Oral Rehabil 1987;14:447-456
41. Neumann L, Buskila D. Epidemiology of fibromyalgia. Curr Pain Headache Rep 2003;7:362-368
42. Hudson JI, Goldenberg DL, Pope HG Jr, et al. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992;92:363-367
43. Triadafilopoulos G, Simms RW, Goldenberg DL. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci 1991;36:59-64
44. Gur A, Karakoc M, Nas K, et al. Cytokines and depression in cases with fibromyalgia. J Rheumatol 2002;29:358-361
45. Dickens C, Creed F. The burden of depression in patients with rheumatoid arthritis. Rheumatology (Oxford) 2001;40:1327-1330
46. Katz PP, Yelin EH. The development of depressive symptoms among women with rheumatoid arthritis: the role of function. Arthritis Rheum 1995;38:49-56
47. Breslau N, Lipton RB, Steward WF, et al. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003;60:1308-1312
48. Marcus DA. Identification of patients with headache at risk of psychological distress. Headache 2000;40:373-376
49. Carroll LJ, Cassidy JD, Cote P. Factors associated with the onset of an episode of depressive symptoms in the general population. J Clin Epidemiol 2003;56:651-658
50. Venable VL, Carlson CR, Wilson J. The role of anger and depression in recurrent headache. Headache 2001;41:21-30
51. Materazzo F, Cathcart S, Pritchard D. Anger, depression, and coping interactions in headache activity and adjustment: a controlled study. J Psychosom Res 2000;49:69-75
52. Tomkins GE, Jackson JL, O'Malley PG, et al. Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 2001;111:54-63
53. Plesh O, Curtis D, Levine J, et al. Amitriptyline treatment of chronic pain in patients with temporomandibular disorders. J Oral Rehabil 2000;27:834-841
54. Mitsikostas DD, Gatzonis S, Thomas A, et al. Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 1997;96:247-251
55. Szanto K, Mulsant BH, Houck P, et al. Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry 2003;60:610-617
56. Fishbain DA. The association of chronic pain and suicide. Semin Clin Neuropsychiatry 1999;4:221-227
57. Chesterton LS, Barlas P, Foster NE, et al. Gender differences in pressure pain threshold in healthy humans. Pain 2003;101:259-266
58. Fillingim RB, Doleys DM, Edwards RR, et al. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine 2003;28:143-150
59. Holtzman J, Saleh K, Kane R. Gender differences in functional status and pain in a Medicare population undergoing elective total hip arthroplasty. Med Care 2002;40:461-470
60. Keefe FJ, Lefebvre JC, Egert JR, et al. The relationship of gender to pain, pain behavior, and disability in osteoarthritis patients: the role of catastrophizing. Pain 2000;87:325-334
61. Unruh AM, Ritchie J, Merskey H. Does gender affect appraisal of pain and pain coping strategies? Clin J Pain 1999;15:31-40
62. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62